24th Jul 2014 12:17
LONDON (Alliance News) - Beximco Pharmaceuticals Ltd Thursday expressed confidence in meeting its expected sales, financial and operational targets for the full year, as it saw pretax profit rise in the half year to end June.
The Dhaka, Bangladesh-based generic pharmaceuticals manufacturer posted a pretax profit of BDT1.02 billion, up from BDT955.6 million, as revenue rose to BDT5.32 billion from BDT4.97 billion. On June 30, a pound purchased 132.44 Bangladesh taka.
The company said it had launched 19 products in its domestic market of Bangladesh, and registered 38 products in 11 overseas markets.
Beximco said that although its export sales had decreased during the first half compared to export sales, it is hopeful of achieving its expected sales for the full year in view of orders in its pipeline.
"We are confident that the company will continue to perform well during the remaining period to achieve its operational and financial targets for the year 2014," Managing Director Nazmul Hassan said in a statement.
Shares in Beximco last traded flat at 13.75 pence Thursday.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Beximco Pharma